Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Language
Publication year range
1.
J Med Genet ; 41(5): 354-9, 2004 May.
Article in English | MEDLINE | ID: mdl-15121773

ABSTRACT

The R337H TP53 mutation is a low-penetrance molecular defect that predisposes to adrenocortical tumour (ACT) formation in Brazilian and possibly other populations. Additional genetic defects may be responsible for the variable expression of ACTs in these cases. The inhibin alpha-subunit gene (INHA) on 2q33-qter has been implicated in mouse adrenocortical tumourigenesis. We studied 46 pediatric patients with ACTs from Brazil for INHA genetic alterations; 39 of these patients were heterozygous carriers of the R337H TP53 mutation. We first mapped the INHA gene by radiation hybrid analysis and determined 10 linked microsatellite markers in an area flanked by D2S1371 and D2S206 on 2q33-qter. These markers were then used for loss of heterozygozity (LOH) studies in nine paired germline and tumour DNA samples. Mapping placed the INHA gene in close proximity to D2S2848 (SHGC11864) with a log of odds (LOD) score of 5.84. LOH for at least one marker in the region was identified in 8/9 tumours (89%). Six patients were heterozygous for three INHA mutations: one in exon 1, 127C>G, and two in exon 2, 3998G>A and 4088G>A, all leading to amino acid substitutions (P43A, G227R, and A257T, respectively). A257T is located in a conserved INHA region, highly homologous to transforming growth factor-beta; both G227R and A257T change polarity, and, in addition, G227R changes the pH. We conclude that these sequence alterations and the detected 2q allelic changes suggest that INHA may be one of the contributing factors needed for ACT formation in pediatric patient carriers of the R337H TP53 mutation.


Subject(s)
Adrenal Cortex Neoplasms/genetics , Genes, p53 , Inhibins/genetics , Mutation , Amino Acid Substitution , Child , Chromosome Mapping , DNA Mutational Analysis , Heterozygote , Humans , Loss of Heterozygosity
2.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;33(11): 1313-5, Nov. 2000. tab
Article in English | LILACS | ID: lil-273208

ABSTRACT

Fetal hemoglobin was measured in HIV1/2 patients under treatment with combined therapy (zidovudine and a protease inhibitor). A total of 143 patients and 103 normal individuals were investigated by the quantitative method of Betke and the semi-quantitative acid elution method of Kleihauer. In the normal person, hemoglobin F makes up less than 1 percent and an increase higher than 1.5 percent was observed in 21.4 percent of HIV patients by the method of Betke and in 24.8 percent of HIV-infected patients by the method of Kleihauer. The quantitative biochemical method of Betke showed that the populations were significantly different (two-tailed Mann-Whitney test). The reason for this hemoglobin F increase might be ascribed to the effect of zidovudine or to direct viral action on gamma chain expression. The finding of a higher F cell frequency indicated by the method of Kleihauer rather suggests that there is an increased F cell clone proliferation rather than an increase in hemoglobin F level in every cell


Subject(s)
Humans , Fetal Hemoglobin/analysis , HIV Infections/blood , Anti-HIV Agents/therapeutic use , Case-Control Studies , Chi-Square Distribution , Erythroid Precursor Cells/drug effects , HIV Infections/drug therapy , HIV Protease Inhibitors/therapeutic use , Statistics, Nonparametric , Zidovudine/therapeutic use
3.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;v. 33(11): 1313-nov. 2000. tab
Article in English | Sec. Est. Saúde SP, SESSP-IALPROD, Sec. Est. Saúde SP, SESSP-IALACERVO | ID: biblio-1061618

ABSTRACT

Fetal hemoglobin was measured in HIV 1/2 patients under treatment with combined therapy (zidovudine and a protease inhbitor). A total of 143 patientes and 103 normal individual were investigated by the quantitative method of Betke and the semi-quantitative acid elution method of Keihauer. In the normal person, hemoglobin F makes up less than.


Subject(s)
HIV-1 , HIV , HIV-2 , Fetal Hemoglobin , Hemoglobins , Zidovudine
4.
Braz J Med Biol Res ; 33(11): 1313-5, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11050661

ABSTRACT

Fetal hemoglobin was measured in HIV1/2 patients under treatment with combined therapy (zidovudine and a protease inhibitor). A total of 143 patients and 103 normal individuals were investigated by the quantitative method of Betke and the semi-quantitative acid elution method of Kleihauer. In the normal person, hemoglobin F makes up less than 1% and an increase higher than 1.5% was observed in 21.4% of HIV patients by the method of Betke and in 24.8% of HIV-infected patients by the method of Kleihauer. The quantitative biochemical method of Betke showed that the populations were significantly different (two-tailed Mann-Whitney test). The reason for this hemoglobin F increase might be ascribed to the effect of zidovudine or to direct viral action on gamma chain expression. The finding of a higher F cell frequency indicated by the method of Kleihauer rather suggests that there is an increased F cell clone proliferation rather than an increase in hemoglobin F level in every cell.


Subject(s)
Fetal Hemoglobin/analysis , HIV Infections/blood , Anti-HIV Agents/therapeutic use , Case-Control Studies , Chi-Square Distribution , Erythroid Precursor Cells/drug effects , Fetal Hemoglobin/metabolism , HIV Infections/drug therapy , HIV Infections/metabolism , HIV Protease Inhibitors/therapeutic use , Humans , Statistics, Nonparametric , Zidovudine/therapeutic use
5.
J Nutr Sci Vitaminol (Tokyo) ; 41(3): 349-61, 1995 Jun.
Article in English | MEDLINE | ID: mdl-7472679

ABSTRACT

Selenium (Se) levels in blood (whole blood, erythrocytes and serum) and blood glutathione peroxidase (GSH-Px) activity were investigated in people living at high altitude in Bolivia (4,000 m above sea level). These parameters were compared to those of people living at low altitude (300 m above sea level). The Se levels in whole blood of the high-altitude subjects did not differ significantly from those of the low-altitude subjects. However, the Se levels in erythrocytes were significantly lower in the high-altitude subjects than in the low-altitude subjects, whereas serum Se levels were higher in the high-altitude subjects than in the low-altitude subjects. GSH-Px activity (Unit/g Hb) was significantly lower in the high-altitude subjects than in the low-altitude subjects. The mean corpuscular Hb concentration (MCHC), an indicator of the age of erythrocytes, in the high-altitude subjects was significantly higher than in the low-altitude subjects. These results show that the GSH-Px activity in the blood of the high-altitude subjects is relatively low. This may be due to their aged erythrocytes and/or to relatively low Se intake in the high-altitude population compared with low-altitude population.


Subject(s)
Altitude , Glutathione Peroxidase/blood , Selenium/blood , Adolescent , Adult , Bolivia , Child , Child, Preschool , Erythrocyte Indices , Erythrocytes/metabolism , Female , Hematocrit , Hemoglobins/metabolism , Humans , Infant , Male , Reference Values
6.
Sci Total Environ ; 145(3): 267-73, 1994 May 16.
Article in English | MEDLINE | ID: mdl-8023133

ABSTRACT

Mercury (Hg) concentrations were determined in spot urine samples of populations living in the highland and lowland areas of Bolivia. The mean levels of the Hg (U-Hg) were 0.43 and 0.34 micrograms Hg/g creatinine in lowlanders and in highlanders, respectively, which did not suggest existence of high-level exposure to Hg in these populations. In both highlanders and lowlanders, there was a marked difference in levels of U-Hg among different populations. Several lines of evidence suggested that local dietary patterns resulted in the observed difference in U-Hg among different populations. Several lines of evidence suggested that local dietary patterns resulted in the observed difference in U-Hg levels, although the responsible food items could not be specified. In most of the populations examined, females showed higher U-Hg levels than males. Other factors possibly related to the observed geographical differences are discussed.


Subject(s)
Altitude , Mercury/urine , Bolivia , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL